SUZHOU,China,Feb. 13,2025-- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 bi
NANJING,China,Feb. 13,2025-- On December 4th,2024,UNESCO inscribed the "Spring Festival,Social Practices of the Chinese People in Celebration of Traditional New Year" on its Representative L
XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).
JAKARTA,Indonesia,Feb. 13,2025-- PT Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) continues to demonstrate resilience amid economic challenges,recording a consolidated net profit of IDR 60.64 trilli
Milestone reaffirms Hyundai Motor Group\'s commitment to safety,quality,design,and performance More than 5,000 vehicles have been tested and driven more than 20-million miles at the facility since ope
SHENZHEN,China,Feb. 13,2025-- On February 13,Hollyland,a leading provider of professional wireless intercom solutions,unveiled its latest innovation,the Cosmo C2. This new product is designed for mul
